FDA advisory committee

FDA to Review Atritech Watchman Device As Alternative to Warfarin or Coumadin in Preventing Strokes From Atrial Fibrillation

Anticoagulation
Prevention
Treatment

April 21, 2009

Recently we reported on the results of the Watchman device trial as an alternative to Coumadin or warfarin in the prevention of strokes among those with atrial fibrillation. We mentioned that it would be reviewed by the FDA Advisory Committee on April 23, 2009. In advance of the review meeting on Thursday, the FDA has …

Subscribe to Our Newsletter

Archives

FDA to Review Atritech Watchman Device As Alternative to Warfarin or Coumadin in Preventing Strokes From Atrial Fibrillation